{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:14:57Z","timestamp":1783350897332,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00401-005-0989-5","type":"journal-article","created":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T14:28:22Z","timestamp":1118068102000},"page":"576-582","source":"Crossref","is-referenced-by-count":48,"title":["Alpha-chemokine receptors CXCR1\u20133 and their ligands in idiopathic inflammatory myopathies"],"prefix":"10.1007","volume":"109","author":[{"given":"Boel","family":"De Paepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"De Keyzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"De Bleecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,4]]},"reference":[{"key":"989_CR1","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","volume":"96","author":"Balashov","year":"1999","unstructured":"Balashov KE, Rottman JB, Weiner HL, Hancock WW (1999) CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96:6873\u20136878","journal-title":"Proc Natl Acad Sci USA"},{"key":"989_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00005072-199706000-00003","volume":"56","author":"Belec","year":"1997","unstructured":"Belec L, Authier FJ, Chazaud B, Piedouillet C, Barlovatz-Meimon G, Gherardi RK (1997) Interleukin (IL)-1beta and IL-1beta mRNA expression in normal and diseased skeletal muscle assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction. J Neuropathol Exp Neurol 56:651\u2013663","journal-title":"J Neuropathol Exp Neurol"},{"key":"989_CR3","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.4049\/jimmunol.153.12.5682","volume":"153","author":"Chuntharapai","year":"1994","unstructured":"Chuntharapai A, Lee J, Hebert CA, Kim KJ (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682\u20135688","journal-title":"J Immunol"},{"key":"989_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"989_CR5","first-page":"1178","volume":"146","author":"De","year":"1995","unstructured":"De Bleecker JL, Engel AG (1995) Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 146:1178\u20131187","journal-title":"Am J Pathol"},{"key":"989_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-8966(98)00126-6","volume":"9","author":"De","year":"1999","unstructured":"De Bleecker JL, Meire VI, Declercq W, Van Aken EH (1999) Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul Disord 9:239\u2013246","journal-title":"Neuromuscul Disord"},{"key":"989_CR7","first-page":"S4","volume":"199","author":"De","year":"2002","unstructured":"De Bleecker J, De Paepe B, Racz G, Schr\u00f6der JM (2002) Beta chemokines and their receptors in inflammatory myopathies. J Neurol Sci 199:S4","journal-title":"J Neurol Sci"},{"key":"989_CR8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","volume":"58","author":"De","year":"2002","unstructured":"De Bleecker JL, De Paepe B, Vanwalleghem IE, Schr\u00f6der JM (2002) Differential expression of chemokines in inflammatory myopathies. Neurology 58:1779\u20131785","journal-title":"Neurology"},{"key":"989_CR9","unstructured":"De Bleecker JL, De Paepe B (2003) The idiopathic inflammatory myopathies. In: Sinha KK, Chandra P (eds) Advances in Clinical Neurosciences, 1st edn. East Zone Neuro CME, Ranchi, pp 353\u2013378"},{"key":"989_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nmd.2004.01.001","volume":"14","author":"De","year":"2004","unstructured":"De Paepe B, Schr\u00f6der JM, Martin JJ, Racz GZ, De Bleecker JL (2004) Localization of the \u03b1-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies. Neuromuscul Disord 14:265\u2013273","journal-title":"Neuromuscul Disord"},{"key":"989_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/1523-1747.ep12289711","volume":"108","author":"Goebeler","year":"1997","unstructured":"Goebeler M, Yoshimura T, Toksoy A, Ritter U, Brocker EB, Gillitzer R (1997) The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol 108:445\u2013451","journal-title":"J Invest Dermatol"},{"key":"989_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z","volume":"184","author":"Goebeler","year":"1998","unstructured":"Goebeler M, Toksoy A, Spandau U, Engelhardt E, Brocker EB, Gillitzer R (1998) The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol 184:89\u201395","journal-title":"J Pathol"},{"key":"989_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","volume":"50","author":"Hengstman","year":"2003","unstructured":"Hengstman GJ, Hoogen FH van den, Barrera P, Netea MG, Pieterse A, Putte LB van de, Engelen BG van (2003) Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol 50:10\u201315","journal-title":"Eur Neurol"},{"key":"989_CR14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.193.6.713","volume":"193","author":"Huang","year":"2001","unstructured":"Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM (2001) Absence of monocyte chemoattactant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713\u2013726","journal-title":"J Exp Med"},{"key":"989_CR15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","volume":"125","author":"Kieseier","year":"2002","unstructured":"Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP (2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125:823\u2013834","journal-title":"Brain"},{"key":"989_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9440(10)64378-7","volume":"160","author":"Kunkel","year":"2002","unstructured":"Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ, Greenberg HB, Hodge MR, Wu L, Butcher EC, Campbell JJ (2002) Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 160:347\u2013355","journal-title":"Am J Pathol"},{"key":"989_CR17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051165","volume":"99","author":"Kuru","year":"2000","unstructured":"Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G (2000) Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 99:585\u2013588","journal-title":"Acta Neuropathol"},{"key":"989_CR18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s004010051041","volume":"97","author":"Liprandi","year":"1999","unstructured":"Liprandi A, Bartoli C, Figarella-Branger D, Pellissier JF, Lepidi H (1999) Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol 97:642\u2013648","journal-title":"Acta Neuropathol"},{"key":"989_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","volume":"63","author":"Lundberg","year":"1995","unstructured":"Lundberg I, Brengman JH, Engel AG (1995) Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol 63:9\u201316","journal-title":"J Neuroimmunol"},{"key":"989_CR20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","volume":"101","author":"Qin","year":"1998","unstructured":"Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746\u2013754","journal-title":"J Clin Invest"},{"key":"989_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","volume":"141","author":"Raju","year":"2003","unstructured":"Raju R, Vasconcelos O, Granger R, Dalakas MC (2003) Expression of IFN-inducible chemokines in inclusion body myositis. J Neuroimmunol 141:125\u2013131","journal-title":"J Neuroimmunol"},{"key":"989_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.V13153","volume":"13","author":"Romagnani","year":"2001","unstructured":"Romagnani P, Lazzeri E, Lasagni L, Mavilia C, Beltrame C, Francalanci M, Rotondi M, Annunziato F, Maurenzig L, Cosmi L, Galli G, Salvadori M, Maggi E, Serio M (2001) IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 13:53\u201364","journal-title":"J Am Soc Nephrol"},{"key":"989_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","volume":"18","author":"Rossi","year":"2000","unstructured":"Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217\u2013242","journal-title":"Annu Rev Immunol"},{"key":"989_CR24","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.162.6.3549","volume":"162","author":"Sauty","year":"1999","unstructured":"Sauty A, Dziejman M, Taha RA, Iarosi AS, Neote K, Garcia-Zepeda, Hamid Q, Luster AD (1999) The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 162:3549\u20133558","journal-title":"J Immunol"},{"key":"989_CR25","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.163.11.6236","volume":"163","author":"Shields","year":"1999","unstructured":"Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH (1999) Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163:6236\u20136243","journal-title":"J Immunol"},{"key":"989_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2990.2000.026002133.x","volume":"26","author":"Simpson","year":"2000","unstructured":"Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN (2000) Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26:133\u2013142","journal-title":"Neuropathol Appl Neurobiol"},{"key":"989_CR27","first-page":"681","volume":"45","author":"Song","year":"2000","unstructured":"Song YH, Neumeister MW, Mowlavi A, Suchy H (2000) Tumor necrosis factor-alpha and lipopolysaccharides induce differentially interleukin-8 and growth related oncogene-alpha expression in human endothelial cell line EA.hy926. Ann Plast Surg 45:681\u2013683","journal-title":"Ann Plast Surg"},{"key":"989_CR28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0923-1811(01)00172-4","volume":"28","author":"Tokuriki","year":"2002","unstructured":"Tokuriki A, Seo N, Ito T, Kumakiri M, Takigawa M, Tokura Y (2002) Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-gamma-producing CD8(+) T cells in IP-10 expression. J Dermatol Sci 28:234\u2013241","journal-title":"J Dermatol Sci"},{"key":"989_CR29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1172\/JCI7707","volume":"104","author":"Topham","year":"1999","unstructured":"Topham PS, Csizmadia V, Soler D, Hines D, Gerard CJ, Salant DJ, Hancock WW (1999) Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 104:1549\u20131557","journal-title":"J Clin Invest"},{"key":"989_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","volume":"108","author":"Xia","year":"2000","unstructured":"Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT (2000) Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer\u2019s disease. J Neuroimmunol 108:227\u2013235","journal-title":"J Neuroimmunol"},{"key":"989_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-5728(01)00463-5","volume":"122","author":"Xia","year":"2002","unstructured":"Xia MQ, Hyman BT (2002) GROa\/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1\/2 and IP-3 kinase pathways and for tau hyperphosphorylation\u2014a role in Alzheimer\u2019s disease? J Neuroimmunol 122:55\u201364","journal-title":"J Neuroimmunol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-005-0989-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-005-0989-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-005-0989-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:36:17Z","timestamp":1683106577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-005-0989-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s00401-005-0989-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}